verified SJR 1,335 · Q1 • database Scopus / SJR & Web of Science indexed

United States · Springer New York

workspace_premium Q1 — Oncology lock_open Open Access

Current Treatment Options in Oncology

Current Treatment Options in Oncology offers in-depth review articles contributed by international experts on the most significant developments in the field. By providing clear, insightful, balanced review articles that emphasize recently published papers of major importance, th...

ISSN: 1527-2729

Publisher: Springer New York

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Visit publisher site menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,335 Q1

H-index 70

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

3.190 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,335

H-index

Docs (year)

107

Docs 3y

350

Total refs

8759

Cites 3y

1590

Citable 3y

348

Cites/Doc 2y

4.78

Ref/Doc

81.86

Immediate OA

3190 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Changing Management in Patients with Papillary Thyroid Cancer

Utilizing prognostic and predictive factors in breast cancer

Evolution of Robotic Surgery in the Treatment of Localized Prostate Cancer

Erratum to: Exercise Therapy in the Management of Solid Tumors

Emerging Role of Genomics and Cell-Free DNA in Breast Cancer

Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?

Diagnosis, Staging, and Surgical Treatment of Malignant Pleural Mesothelioma

Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery

Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer

Clinical Impact of the 2016 Update to the WHO Lymphoma Classification

Clinical applications of hormonal therapy in ovarian cancer

Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and/or Adjuvant

SHOW MORE ARTICLES

Chemotherapeutic options for primary brain tumors

Acupuncture in the Oncology Setting: Clinical Trial Update

CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia

Brain metastases

BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?

Bone Targeted Therapies in Early Breast Cancer

BEYOND KRAS: Other Markers and Potential Treatment Strategies for KRAS Mutant and Wild-type Patients

Basic Assessment of the Older Cancer Patient

Angiosarcomas and Taxanes

Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS

Advancing Immunotherapy in Metastatic Breast Cancer

Advanced renal cell carcinoma

FAQs

Current Treatment Options in Oncology has an SJR of 1,335 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 3190 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Current Treatment Options in Oncology is 29%.

Current Treatment Options in Oncology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Treatment Options in Oncology?

What is the APC / publication cost?

What is the acceptance rate?